Search Count: 15
 |
Crystal Structure Of The Rab27A Fusion With Slp2A-Rbda1 Effector For Sf4 Pocket Drug Targeting
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: GNP, MG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: 06D, GNP, MG, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: GNP, MG, GOL, 05Y |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000065
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, HWT, MG |
 |
Leishmania Major N-Myristoyltransferase In Complex With Quinazoline Inhibitor Imp-0000811
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, MG, HWZ |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000081
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, HWQ, MG |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000101
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, MG, HXE |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000105
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, DMS, MG, HXW |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000877
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MG, HWW, MYA |
 |
Leishmania Major N-Myristoyltransferase In Complex With Thienopyrimidine Inhibitor Imp-0000096
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, MG, HWN |
 |
Leishmania Major N-Myristoyltransferase In Complex With Quinazoline Inhibitor Imp-0000169
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, MG, HXN |
 |
Leishmania Major N-Myristoyltransferase In Complex With Quinazoline Inhibitor Imp-0000906
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2020-05-06 Classification: TRANSFERASE Ligands: MYA, HXQ, HZ5, HZ8, MG |
 |
Crystal Structure Of The Fifth Bromodomain Of Human Pb1 In Complex With Compound 10
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2016-06-01 Classification: TRANSCRIPTION Ligands: 5XM |
 |
Crystal Structure Of The Fifth Bromodomain Of Human Pb1 In Complex With Compound 18
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2016-06-01 Classification: TRANSCRIPTION Ligands: EDO, 5XL |
 |
Crystal Structure Of The Fifth Bromodomain Of Human Pb1 In Complex With Compound 28
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2016-06-01 Classification: TRANSCRIPTION Ligands: 5XK, DMS, EDO |